160 related articles for article (PubMed ID: 38704585)
1. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585
[TBL] [Abstract][Full Text] [Related]
2. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
[TBL] [Abstract][Full Text] [Related]
3. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study.
Fukihara J; Sakamoto K; Ikeyama Y; Furukawa T; Teramachi R; Kataoka K; Kondoh Y; Hashimoto N; Ishii M
Respir Res; 2024 May; 25(1):202. PubMed ID: 38730452
[TBL] [Abstract][Full Text] [Related]
5. Involvement of necroptotic cell death in macrophages in progression of bleomycin and LPS-induced acute exacerbation of idiopathic pulmonary fibrosis.
Koike A; Hayashi K; Fujimori K
Eur J Pharmacol; 2024 Jun; 972():176572. PubMed ID: 38614381
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis.
Lavis P; Pingitore J; Doumont G; Garabet A; Van Simaeys G; Lacroix S; Passon N; Van Heymbeek C; De Maeseneire C; Allard J; Collin A; Huaux F; Decaestecker C; Salmon I; Goldman S; Cardozo AK; Bondue B
Respir Res; 2023 Oct; 24(1):254. PubMed ID: 37880678
[TBL] [Abstract][Full Text] [Related]
7. CSF3 aggravates acute exacerbation of pulmonary fibrosis by disrupting alveolar epithelial barrier integrity.
Guo B; Liu W; Ji X; Xi B; Meng X; Xie W; Sun Y; Zhang M; Liu P; Zhang W; Yan X; Chen B
Int Immunopharmacol; 2024 Jun; 135():112322. PubMed ID: 38788452
[TBL] [Abstract][Full Text] [Related]
8. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.
Hanaka T; Kido T; Noguchi S; Yamada S; Noguchi H; Guo X; Nawata A; Wang KY; Oda K; Takaki T; Izumi H; Ishimoto H; Yatera K; Mukae H
BMC Pulm Med; 2019 Dec; 19(1):265. PubMed ID: 31888585
[TBL] [Abstract][Full Text] [Related]
9. Increased lipocalin-2 expression in pulmonary inflammation and fibrosis.
Galaris A; Fanidis D; Tsitoura E; Kanellopoulou P; Barbayianni I; Ntatsoulis K; Touloumi K; Gramenoudi S; Karampitsakos T; Tzouvelekis A; Antoniou K; Aidinis V
Front Med (Lausanne); 2023; 10():1195501. PubMed ID: 37746070
[TBL] [Abstract][Full Text] [Related]
10. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respirology; 2020 Mar; 25(3):275-280. PubMed ID: 31270920
[TBL] [Abstract][Full Text] [Related]
11. IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis.
Nakanishi Y; Horimasu Y; Yamaguchi K; Sakamoto S; Masuda T; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
PLoS One; 2021; 16(6):e0252594. PubMed ID: 34086758
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
13. CoQ10 enhances the efficacy of airway basal stem cell transplantation on bleomycin-induced idiopathic pulmonary fibrosis in mice.
Liu H; Liu S; Jiang J; Zhang Y; Luo Y; Zhao J; Xu J; Xie Y; Liao W; Wang W; Nie Y; Li S; Deng W
Respir Res; 2022 Feb; 23(1):39. PubMed ID: 35219329
[TBL] [Abstract][Full Text] [Related]
14. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.
Makiguchi T; Yamada M; Yoshioka Y; Sugiura H; Koarai A; Chiba S; Fujino N; Tojo Y; Ota C; Kubo H; Kobayashi S; Yanai M; Shimura S; Ochiya T; Ichinose M
Respir Res; 2016 Sep; 17(1):110. PubMed ID: 27596748
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
16. Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
Mackinnon AC; Gibbons MA; Farnworth SL; Leffler H; Nilsson UJ; Delaine T; Simpson AJ; Forbes SJ; Hirani N; Gauldie J; Sethi T
Am J Respir Crit Care Med; 2012 Mar; 185(5):537-46. PubMed ID: 22095546
[TBL] [Abstract][Full Text] [Related]
17. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Mazur W; Miura S; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Res; 2020 Jun; 21(1):145. PubMed ID: 32527263
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin-2 promotes acute lung inflammation and oxidative stress by enhancing macrophage iron accumulation.
An HS; Yoo JW; Jeong JH; Heo M; Hwang SH; Jang HM; Jeong EA; Lee J; Shin HJ; Kim KE; Shin MC; Roh GS
Int J Biol Sci; 2023; 19(4):1163-1177. PubMed ID: 36923935
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice.
Chen Y; Wang T; Liang F; Han J; Lou Z; Yu Y; Li J; Zhan T; Gu Y; Dong L; Jiang B; Zhang W; Wu M; Lu Y
Theranostics; 2024; 14(7):2794-2815. PubMed ID: 38773984
[No Abstract] [Full Text] [Related]
20. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.
Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y
Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
